McClintick JN, McBride WJ, Bell RL, Ding Z-M, Liu Y, Xuei X, et al
Staying Comfortable on GLP-1 Managing Side Effects Effectively Nausea is the most common side effect, particularly during the first few weeks and after dose increases
When NNMT activity is inhibited, these methyl donors become available for other methylation reactions in the body
Multiple SGLT2 inhibitors have been approved to treat adults with CKD over the past 5 years, and in 2021, the nonsteroidal mineralocorticoid receptor antagonist finerenone (Kerendia, Bayer) was approved to lower risk for renal and CV complications for adults with type 2 diabetes and CKD
GHRP2 - Growth hormone releasing peptide -- stimulates GH release Ipamorelin - Stimulates growth hormone and IGF-1 Melanotan II - Increases melanin production and tanning AOD-9604 Fat metabolism and weight loss